Kelly Dooley and Gavin Churchyard on TB prevention in people with HIV - a podcast by The Lancet HIV

Kelly Dooley (Johns Hopkins University, USA) and Gavin Churchyard (Aurum Institute, South Africa) discuss their trial on tuberculosis prevention in people with HIV taking dolutegravir-based antiretroviral therapy with Deputy Editor Philippa Harris. 

Further episodes of The Lancet HIV in conversation with

Further podcasts by The Lancet HIV

Website of The Lancet HIV